Akebia Therapeutics
AKBA
#6958
Rank
HK$3.17 B
Marketcap
HK$15.08
Share price
4.02%
Change (1 day)
112.25%
Change (1 year)

Akebia Therapeutics (AKBA) - Cash on Hand

Cash on Hand as of June 2024 : HK$0.30 Billion

According to Akebia Therapeutics's latest financial reports the company has HK$0.30 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Akebia Therapeutics - Cash on Hand chart (from 2013 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$0.33 B-52.57%
2022-12-31HK$0.70 B-39.49%
2021-12-31HK$1.16 B-43.92%
2020-12-31HK$2.08 B81.08%
2019-12-31HK$1.15 B-54.33%
2018-12-31HK$2.51 B1.44%
2017-12-31HK$2.48 B22.99%
2016-12-31HK$2.01 B88.13%
2015-12-31HK$1.07 B27.02%
2014-12-31HK$0.84 B234.65%
2013-12-31HK$0.25 B1884.67%
2012-12-31HK$12.72 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$70.05 B 22,713.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$108.99 B 35,394.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$157.79 B 51,286.11%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.10 B 586.69%๐Ÿ‡บ๐Ÿ‡ธ USA